Benefit of Early Protocol Biopsy and Treatment of Subclinical Rejection

NCT00885820 · clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
240
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Astellas Pharma Inc

Collaborators